---
title: "KRAS Mt"
slug: "kras-mt"
date: "2023-11-02"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Molecular biology-of-NSCLC]]

# KRAS Mt

- 25% of ADCL (Cancer Discov 2017;7:596; CCR 2018;24:1038), a/w smoking (transversions: G12C 40% of KRAS Mt, G12V) but present in 4% of never-smokers (transitions: G12D).
- Confers worse prog.
- KRAS G12C specific inhibitor available.
- Targetable driver oncogenes are generally mutually exclusive in tx-naÃ¯ve tumors

